From: Neutrophil/lymphocyte ratio has a prognostic value for patients with terminal cancer
More than 4 weeks
Up to 4 weeks
P value
NLR, mean ± standard deviation
6.15 ± 5.86
29.82 ± 44.19
P < 0.00000001